Brief: ImmunoPrecise's Subsidiary Talem In Research Collaboration With Astellas

Mindwalk Holdings

30/03/2023 14:56

March 30 (Reuters) - Immunoprecise Antibodies Ltd
 IPA.O :
    * IMMUNOPRECISE’S SUBSIDIARY TALEM ENTERS INTO EXCLUSIVE
RESEARCH
COLLABORATION AND LICENSE OPTION AGREEMENT WITH ASTELLAS
    * IMMUNOPRECISE ANTIBODIES LTD - DEAL FOCUSES ON IN SILICO
AND DE
NOVO DISCOVERY AND DEVELOPMENT OF ANTIBODIES AGAINST TUMOR
MICROENVIRONMENT TARGETS

Source text for Eikon:  ID:nBw37jm3pa 
Further company coverage:  IPA.O 

 ((Reuters.Briefs@thomsonreuters.com;))